Estudio de la diversidad en el tratamiento de la neumonía adquirida en la comunidad

Valverde Garrido, R; Vegas Serrano, A; Crespo Rico, S; Vereda Ortiz, A; Díez Sebastián, J.
Rev. esp. quimioter ; 15(4): 346-351, dic. 2002.
Artículo en Es | IBECS (España) | ID: ibc-18747

Documentos relacionados

  1. The Microbial Etiology of Community-Acquired Pneumonia in Adults: from Classical Bacteriology to Host Transcriptional Signatures.
  2. A hypervirulent Acinetobacter baumannii strain has robust anti-phagocytosis ability.
  3. Shift in bacterial etiology from the CAPNETZ cohort in patients with community-acquired pneumonia: data over more than a decade.
  4. Severe Community-Acquired Pneumonia in Immunocompromised Patients.
  5. Finding the Pathogen in Community-acquired Pneumonia.
  6. Editorial Commentary: Distinguishing Postobstructive Lung Infection From Community-Acquired Pneumonia.
  7. Identification of priority pathogens for aetiological diagnosis in adults with community-acquired pneumonia in China: a multicentre prospective study.
  8. Childhood community-acquired pneumonia.
  9. Validation of JRS atypical pneumonia score in patients with community-acquired Chlamydia psittaci pneumonia.
  10. Understanding Early and Late Endpoints in Registrational Trials of Community-acquired Bacterial Pneumonia.